About this trial
Laparoscopic cholecystectomy is a commonly performed minimally invasive surgical procedure; however, postoperative pain, nausea, and delayed recovery remain clinically relevant problems. Glucocorticoids such as dexamethasone are widely used in perioperative care for the prevention of postoperative nausea and vomiting and as part of multimodal analgesia strategies.
This prospective randomized controlled trial aims to compare the effects of moderate- and high-dose intravenous dexamethasone administered intraoperatively on postoperative recovery in patients undergoing elective laparoscopic cholecystectomy. The primary outcomes include postoperative nausea and vomiting, inflammatory markers (CRP and WBC), and Quality of Recovery-15 (QoR-15) scores. Secondary outcomes include postoperative pain scores, intraoperative remifentanil consumption, postoperative opioid consumption, and adverse events.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
ASA physical status I-II
Scheduled for elective laparoscopic cholecystectomy
Undergoing general anesthesia
Disqualifiers
Patients younger than 18 years or older than 65 years
Known allergy to dexamethasone
ASA physical status III or higher
Surgical procedures lasting longer than 120 minutes
Trial design
Treatments tested in this trial
- Saline (0.9% NaCl)
- TAP Block
- moderate dose Dexamethasone
- High dose dexamethasone